IFNγ and CTLA-4 Drive Hepatic CD4 T-Cell Tolerance and Protection From Autoimmunity in Mice

Area of Science:

• Immunology
• Hepatology
• Neuroinflammation

Background:

• The liver possesses a unique ability to induce immune tolerance to its own antigens.
• While beneficial for preventing autoimmune conditions, liver tolerance can hinder immune surveillance against infections and cancer.

Purpose of the Study:

• To investigate the specific immune mechanisms underlying the establishment of hepatic tolerance.
• To identify key molecular players involved in maintaining liver immune homeostasis.

Main Methods:

• Utilized C-reactive protein (CRP)-myelin basic protein (MBP) transgenic mice expressing MBP in hepatocytes.
• Transferred MBP-specific CD4 T cells and employed antibody-based depletion or blocking strategies to analyze tolerance mechanisms.

Main Results:

• Interferon-gamma (IFNγ) induced the upregulation of recruitment molecules, facilitating T cell entry into the liver.
• Translocated CD4 T cells differentiated into regulatory T cells and expressed immune checkpoint molecules like CTLA-4.
• Blocking both IFNγ and CTLA-4 abrogated tolerance, leading to neuroinflammation.

Conclusions:

• IFNγ-mediated T cell redirection and CTLA-4 expression are essential for inducing liver tolerance.
• These pathways represent potential therapeutic targets for modulating liver tolerance in autoimmune diseases.